GlaxoSmithKline Plans 5 New Cancer Drugs
690168
LONDON -- GlaxoSmithKline PLC, the world's second-largest pharmaceutical company, said Monday that it expects to introduce five new cancer treatments through 2010.
453741
New drugs that are currently in clinical trials for muscle-wasting diseases could become the next big thing for athletes.
506148
It's running trials to see if the drug can be used in earlier stages of cancer.
401212
The US National Cancer Institute announced a new five-year plan on Monday to develop the use of tiny tools to fight cancer, saying nanotechnology
375255
Serono is teaming up with California-based biotech firm CancerVax Corp. to develop a new skin cancer drug, as Europe's biggest biotech firm aims to strengthen its pipeline by moving into cancer treatment.
358806
GlaxoSmithKline may be able to produce a vaccine in mass quantities to protect humans from bird flu by next year, the drugmaker said Wednesday following encouraging results from a clinical trial.
312982
MONDAY, July 23 (HealthDay News) -- A newer generation of breast cancer medications added months to the lives of patients with the most advanced form of the disease, according to the first study of its kind.
346505
Mumbai, Oct. 15: GlaxoSmithkline (GSK) today announced a breakthrough in malaria vaccine development. This followed encouraging results from a paediatric safety and efficacy clinical trial of the vaccine in Africa.
347692
GlaxoSmithKline yesterday said it would publish all details of its clinical drug trials after being accused of concealing information that its leading antidepressant could be harmful to children.
502254
The European Medicines Agency has  recommended conditional approval of GlaxoSmithKline Plc's new  breast cancer pill Tykerb, Europe's biggest drugmaker said on  Friday.
449009
A new type of drug shows growing promise as a more potent way for many breast-cancer patients to significantly cut their risk of recurrence, researchers reported yesterday.
509470
Pharmaceutical giant GlaxoSmithKline PLC reported a 21 percent increase in fourth-quarter net profit on Thursday, as additional offerings of its key anti-depressant drugs began to offset some of the generic competition that has curtailed the company's sales.
315747
GlaxoSmithKline Plc GSK.L has agreed  to release all clinical studies of its drugs to settle a  lawsuit that accused it of withholding negative information  about the antidepressant Paxil, the New York Attorney General's  office said on Thursday.
251574
U.S. health regulators have approved GlaxoSmithKline Plc's   pill Tykerb for patients with advanced breast cancer after other treatments have failed, a company spokeswoman said on Tuesday.
712506
GlaxoSmithKline Plc announced further  clinical trial results on Sunday underlining the ability of a  drug combination including its product Tykerb to fight breast  cancer that has spread to the brain.
470547
GlaxoSmithKline Plc , Europe's biggest drugmaker, is set to seek European Union approval for its experimental breast cancer drug Tykerb, a spokesman said on Sunday.
307115
GlaxoSmithKline Plc&#39;s experimental vaccine was effective against a virus that causes cervical cancer in a study, the first to show the treatment may provide protection against the No.